PAX Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $348K | Sell |
3,142
-812
| -21% | -$90K | 0.07% | 176 |
|
|
2025
Q1 | $443K | Sell |
3,954
-1,189
| -23% | -$133K | 0.08% | 179 |
|
|
2024
Q4 | $475K | Sell |
5,143
-2,957
| -37% | -$273K | 0.09% | 171 |
|
|
2024
Q3 | $679K | Sell |
8,100
-392
| -5% | -$32.9K | 0.12% | 145 |
|
|
2024
Q2 | $583K | Buy |
8,492
+861
| +11% | +$59.1K | 0.11% | 154 |
|
|
2024
Q1 | $559K | Sell |
7,631
-176
| -2% | -$12.9K | 0.11% | 173 |
|
|
2023
Q4 | $576K | Sell |
7,807
-584
| -7% | -$43.1K | 0.12% | 165 |
|
|
2023
Q3 | $629K | Sell |
8,391
-2
| -0% | -$150 | 0.14% | 128 |
|
|
2023
Q2 | $647K | Sell |
8,393
-716
| -8% | -$55.2K | 0.15% | 127 |
|
|
2023
Q1 | $756K | Buy |
9,109
+28
| +0.3% | +$2.32K | 0.18% | 88 |
|
|
2022
Q4 | $780K | Sell |
9,081
-3,325
| -27% | -$285K | 0.2% | 82 |
|
|
2022
Q3 | $765K | Buy |
12,406
+85
| +0.7% | +$5.24K | 0.2% | 84 |
|
|
2022
Q2 | $762K | Buy |
12,321
+579
| +5% | +$35.8K | 0.19% | 79 |
|
|
2022
Q1 | $698K | Buy |
11,742
+2,039
| +21% | +$121K | 0.16% | 115 |
|
|
2021
Q4 | $705K | Buy |
9,703
+13
| +0.1% | +$945 | 0.16% | 119 |
|
|
2021
Q3 | $677K | Buy |
9,690
+120
| +1% | +$8.38K | 0.17% | 112 |
|
|
2021
Q2 | $659K | Buy |
9,570
+491
| +5% | +$33.8K | 0.17% | 102 |
|
|
2021
Q1 | $587K | Buy |
9,079
+541
| +6% | +$35K | 0.17% | 98 |
|
|
2020
Q4 | $497K | Buy |
8,538
+1,526
| +22% | +$88.8K | 0.16% | 94 |
|
|
2020
Q3 | $443K | Buy |
7,012
+1,672
| +31% | +$106K | 0.16% | 94 |
|
|
2020
Q2 | $411K | Buy |
5,340
+333
| +7% | +$25.6K | 0.16% | 87 |
|
|
2020
Q1 | $399K | Buy |
5,007
+351
| +8% | +$28K | 0.17% | 74 |
|
|
2019
Q4 | $312K | Buy |
+4,656
| New | +$312K | 0.13% | 88 |
|